Reproterol

Reproterol
Systematic (IUPAC) name
(RS)-7-(3-{[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino}propyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Inhalation (MDI), IV
Legal status
Legal status
  • ℞-only (DE)
Identifiers
CAS Number 54063-54-6 YesY
ATC code R03AC15 (WHO)
PubChem CID 25654
ChemSpider 23898 N
UNII 11941YC6RN YesY
KEGG D08474 YesY
ChEMBL CHEMBL1095607 N
Chemical data
Formula C18H23N5O5
Molar mass 389.406 g/mol
 NYesY (what is this?)  (verify)

Reproterol (INN) is a short-acting[1] β2 adrenoreceptor agonist used in the treatment of asthma.[2]

References

  1. Küpper, T; Goebbels, K; Kennes, LN; Netzer, NC (December 2012). "Cromoglycate, reproterol, or both—what's best for exercise-induced asthma?". Sleep & breathing = Schlaf & Atmung 16 (4): 1229–35. PMID 22198635.
  2. Virchow JC Jr. Reproterol: beta-2-agonist, theophylline, or both? Respiration. 1999;66(3):210-1. PMID 10364735
This article is issued from Wikipedia - version of the Sunday, April 10, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.